Brufani M - Search Results

1

Structure-activity relationships in 4-deoxypyrido[1',2'-1,2]imidazo[5,4-c]rifamycin SV derivatives.

Cellai L, Cerrini S, Segre AL, Battistoni C, Cossu G, Mattogno G, Brufani M, Marchi E, Venturini AP. Cellai L, et al. Among authors: brufani m. Farmaco. 1989 Feb;44(2):97-107. Farmaco. 1989. PMID: 2775416

2

A study of structure-activity relationships in 4-deoxypyrido[1',2'-1,2]imidazo[5,4-c]rifamycin SV derivatives by electron spectroscopy for chemical analysis and 1H NMR.

Cellai L, Cerrini S, Segre A, Battistoni C, Cossu G, Mattogno G, Brufani M, Marchi E. Cellai L, et al. Among authors: brufani m. Mol Pharmacol. 1985 Jan;27(1):103-8. Mol Pharmacol. 1985. PMID: 3965922

3

The synthesis of 4-deoxypyrido[1',2'-1,2]imidazo[5,4-c]rifamycin SV derivatives.

Brufani M, Cellai L, Marchi E, Segre A. Brufani M, et al. J Antibiot (Tokyo). 1984 Dec;37(12):1611-22. doi: 10.7164/antibiotics.37.1611. J Antibiot (Tokyo). 1984. PMID: 6526730 Free article.

4

Structure-activity relationships in open ansa-chain rifamycin S derivatives as inhibitors of HIV-1 reverse transcriptase.

Bartolucci C, Cellai L, Marzano M, Segre A, Brufani M, Filocamo L, Bianco AD, Guiso M, Brizzi V, Benedetto A, et al. Bartolucci C, et al. Among authors: brufani m. Farmaco. 1995 Sep;50(9):587-93. Farmaco. 1995. PMID: 7495468

5

Synthesis of 2-hydroxyacetyl-7-acetyl-xanthone, a new xanthone derivative endowed with antianaphylactic, analgesic, and antiinflammatory activities.

Bianco A, Passacantilli P, Righi G, Brufani M, Cellai L, Marchi E, Milani MR. Bianco A, et al. Among authors: brufani m. Farmaco. 1989 Jun;44(6):547-54. Farmaco. 1989. PMID: 2803446

6

4-Deoxypyrido[1',2':1,2]imidazo[5,4-c]rifamycin SV derivatives. A new series of semisynthetic rifamycins with high antibacterial activity and low gastroenteric absorption.

Marchi E, Montecchi L, Venturini AP, Mascellani G, Brufani M, Cellai L. Marchi E, et al. Among authors: brufani m. J Med Chem. 1985 Jul;28(7):960-3. doi: 10.1021/jm00145a020. J Med Chem. 1985. PMID: 4009619

7

X-ray crystal structure of 4-deoxy-3'-bromopyrido[1',2'-1,2]imidazo[5,4-c]rifamycin S.

Brufani M, Cellai L, Cerrini S, Fedeli W, Marchi E, Segre A, Vaciago A. Brufani M, et al. J Antibiot (Tokyo). 1984 Dec;37(12):1623-7. doi: 10.7164/antibiotics.37.1623. J Antibiot (Tokyo). 1984. PMID: 6549316 Free article.

8

Structure-activity relationships in the ansamycins. Molecular structure and activity of 3-carbomethoxy rifamycin S.

Brufani M, Cellai L, Cerrini S, Fedeli W, Segre A, Vaciago A. Brufani M, et al. Mol Pharmacol. 1982 Mar;21(2):394-9. Mol Pharmacol. 1982. PMID: 7048060

9

Rifamycins as inhibitors of retroviral reverse transcriptase from M-MuLV, RAV-2, and HIV-1.

Bartolucci C, Cellai L, Di Filippo P, Segre A, Brufani M, Filocamo L, Bianco AD, Guiso M, Brizzi V, Benedetto A, et al. Bartolucci C, et al. Among authors: brufani m. Farmaco. 1992 Nov;47(11):1367-83. Farmaco. 1992. PMID: 1283514

10

Synthesis and activity studies of N-[omega-N'-(adamant-1'-yl)aminoalkyl]- 2-(4'-dimethylaminophenyl)acetamides: in the search of selective inhibitors for the different molecular forms of acetylcholinesterase.

Perola E, Cellai L, Brufani M. Perola E, et al. Among authors: brufani m. Bioorg Med Chem Lett. 1998 Mar 17;8(6):575-80. doi: 10.1016/s0960-894x(98)00076-6. Bioorg Med Chem Lett. 1998. PMID: 9871563

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

63 results

Search Page

Filters